[Prostanorm对从慢性细菌性前列腺炎患者中分离出来的微生物持续潜力的影响]
O A Pashinina1, O L Kartashova1, T M Pashkova1
1Orenburg Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Orenburg, Russia.
在慢性细菌性前列腺炎中,Prostanorm有效地降低了微生物持久性因素,如生物膜形成和抗溶酶活性. 这项研究证明了其潜在的细菌静止和抗炎作用.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性细菌性前列腺炎 (CBP) 通常是由机会性尿病原体引起的.
- 前列腺分泌物中持续存在的微生物有助于病情的慢性化.
- 了解微生物持久性机制对于开发有效的治疗方法至关重要.
研究的目的:
- 评估Prostanorm对CBP涉及的关键泌尿病原体的持久性潜力的影响.
- 调查Prostanorm对细菌抗溶酶活性,生物膜形成和抗细胞因子活性的影响.
主要方法:
- 在实验室中使用从CBP患者中分离出来的尿路病原体 (例如,大肠杆菌,黄金葡萄球菌) 的研究.
- 酶免疫试验用于评估对调节性细胞因子 (IL-4,IL-6,IL-8,TNF,IL-17A) 的抗细胞因子活性.
- 光度法用于评估抗溶酶活性和生物膜形成.
主要成果:
- 普罗斯坦诺姆对微生物抗溶酶活性和生物膜形成表现出抑制作用.
- 在所有测试物种中观察到对IL-17A和TNF-α的抗细胞因子活性显著下降.
- 针对大肠杆菌和凝结酶阴性葡萄球菌,针对IL-4,IL-6和IL-8的抗细胞因子活性特别减少.
结论:
- 普罗斯坦诺姆可以在体外减少机会性微生物的持久性因素.
- 这些发现表明Prostanorm的潜在前列腺增生,细菌静止和抗炎作用.
- 这突显了Prostanorm在管理CBP方面的可能治疗机制.
更多相关视频
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
07:25High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
Published on: February 23, 2021
相关概念视频
Antimicrobial Effectiveness
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Microorganisms in Medicine and Therapeutics
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Stringent Response in E. coli
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
